Lawmakers blast pharma for ‘outrageous’ prices and ‘anticompetitive conduct’ in culmination of 3-year probe fkansteiner Fri, 12/10/2021 – […]
Month: December 2021
GlaxoSmithKline vet departs for Vifor, the rumored target of a $7.1B CSL buyout fkansteiner Fri, 12/10/2021 – 09:31
Fierce Pharma Asia—China’s new NRDL; Biocon-Viatris biosimilar merger?; Avistone’s $200M series A aliu Fri, 12/10/2021 – 02:51
bmj;375/dec10_6/n3054/FAF1faPhoto credit: Arre BekkeringDutch general practitioner Paul Bekkering recalled the 1970s and confronting a Roman Catholic padre demonstrating […]
AbstractTwo ideas precede the modern Precautionary Principle. First, that prevention is better than cure, exemplified by an aphorism […]
The UK’s medicines and devices regulator will stop work that “does not add value” and lose over 100 […]
New Zealand will become the first country in the world to implement a “tobacco-free generation” policy, its government […]
AbstractMost biomedical research is flawed. While existing reporting guidelines (eg, STROBE, CONSORT, STARD) highlight the strengths of already […]
A peptide known to prevent the protein error that gives rise to Parkinson’s disease has been optimized by […]
The drug is additionally undergoing assessment with the Medicines and Healthcare products Regulatory Agency for a marketing authorisation […]